May 29, 2020 Not intended for U.S. and UK Media - American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program): Efficacy of Vitrakvi™ (larotrectinib) further established with continued high response rates and durable response in updated analyses in adult patients and quality of life data in adult and pediatric patients with TRK fusion cancerRead more
May 29, 2020 Bayer furthers commitment to greater transparency on glyphosate and stakeholder engagement through new dialogue event seriesRead more